Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended					9 Months Ended		12 Months Ended
	Sep. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
OPERATING ACTIVITIES:
Net loss	$ (6,270)			$ (116,902)		$ (66,857)	$ (175,987)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization						3,416	5,763
Provision for sales returns						(215)	134
Amortization of deferred financing cost and debt discounts						321	321
Issuance of common stock						0	43
Stock-based compensation						6,771	11,854
Gain from decrease of contingent earn-out liability fair value	0			(774)		0	(5,240)	$ 5,240
Change in inventory provisions						213	0
Loss (gain) in connection with the change in warrant fair value	(567)			(5,528)		(2,410)	2,365
Gain in connection with settlement of note payable	0			0		0	(2,012)
Loss on initial issuance of equity	0			12,834		0	18,669
Impairment loss on goodwill	0		$ 500	90,921	$ 29,000	0	119,941	120,409	[1]
Impairment loss on intangibles	0	$ 16,700		3,118		39,445	3,118	3,118
Allowance for doubtful accounts and other						59	219
Changes in assets and liabilities:
Accounts receivable						1,186	5,326
Inventory						11,960	2,588
Prepaid and other current assets						1,942	3,351
Accounts payable, accrued and other liabilities						(4,289)	(9,994)
Cash used in operating activities						(8,458)	(19,541)
INVESTING ACTIVITIES:
Purchase of fixed assets						(80)	(29)
Purchase of Step and Go assets						(125)	0
Cash used in investing activities						(205)	(29)
FINANCING ACTIVITIES:
Proceeds from equity offering, net of issuance costs						0	27,007
Repayments on note payable to Smash						(518)	(2,868)
Payment of Squatty Potty earn-out						0	(3,983)	(3,983)
Borrowings from MidCap credit facilities						63,978	107,678
Repayments for MidCap credit facilities						(71,165)	(116,924)
Insurance obligation payments						(788)	(1,778)
Insurance financing proceeds						986	2,099
Cash provided (used) by financing activities						(7,507)	11,231
Foreign currency effect on cash, cash equivalents, and restricted cash						42	(936)
Net change in cash and restricted cash for the year						(16,128)	(9,275)
Cash and restricted cash at beginning of year		$ 46,629	29,040		$ 38,315	46,629	38,315	38,315
Cash and restricted cash at end of year	30,501		46,629	29,040		30,501	29,040	46,629
RECONCILIATION OF CASH AND RESTRICTED CASH:
Cash	27,955			25,997		27,955	25,997
Restricted Cash—Prepaid and other current assets	2,417			2,914		2,417	2,914
Restricted cash—Other non-current assets	129			129		129	129
TOTAL CASH AND RESTRICTED CASH	$ 30,501		$ 46,629	$ 29,040		30,501	29,040	$ 46,629
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for interest						1,457	1,409
Cash paid for taxes						90	58
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Non-cash consideration paid to contractors						321	1,137
Fair value of warrants issued in connection with equity offering						0	18,982
Issuance of common stock related to exercise of warrants						0	767
Issuance of common stock						0	43
Exercise of prefunded warrants						$ 0	$ 15,039

[1] The Company evaluated current economic conditions during 2022, including the impact of the Federal Reserve further increasing the risk-free interest rate, as well as the inflationary pressure on product and labor costs and operational impacts attributable to continued global supply chain disruptions. The Company believed that these conditions were factors in our market capitalization falling below the book value of net assets during the fiscal quarters ending March 31, 2022 and September 30, 2022. Accordingly, the Company concluded a triggering event had occurred in each of these periods and performed interim goodwill impairment analyses. As a result, the Company recorded a goodwill impairment charge of approximately $29.0 million and $90.9 during the three months ended March 31, 2022 and September 30, 2022, respectively. On October 4, 2022, the Company acquired Step and Go, a brand in the health and Wellness category, for $0.7 million. As part of the purchase price allocation of the acquisition, $0.5 million was attributed to goodwill. As our market capitalization was further reduced below net assets as of December 31, 2022, we concluded a triggering event has occurred to test goodwill, an impairment loss on goodwill of $0.5 million was recorded for the three months ended December 31, 2022, which is included in impairment loss on goodwill in the Consolidated Statement of Operations for the year-ended December 31, 2022.